| 期刊論文1. | Miller, M. R.、Hankinson, J.、Brusasco, V.、Burgos, F.、Casaburi, R.、Coates, A.、Crapo, R.、Enright, P.、van der Grinten, C. P. M.、Gustafsson, P.、Jensen, R.、Johnson, D. C.、MacIntyre, N.、McKay, R.、Navajas, D.、Pedersen, O. F.、Pellegrino, R.、Viegi, G.、Wanger, J.(2005)。Standardisation of spirometry。European Respiratory Journal,26(2),319-338。 | 2. | Woywodt, A.、Streiber, F.、De Groot, K.、Regelsberger, H.、Haller, H.、Haubitz, M.(2003)。Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis。The Lancet,361(9353),206-210。 | 3. | Conraads, V. M.、Pattyn, N.、De Maeyer, C.、Beckers, P. J.、Coeckelberghs, E.、Cornelissen, V. A.、Possemiers, N.(2015)。Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the SAINTEX-CAD study。International Journal of Cardiology,179,203-210。 | 4. | Brogan, P. A.、Bose, A.、Burgner, D.、Shingadia, D.、Tulloh, R.、Michie, C.(2002)。Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research。Archives of Disease in Childhood,86(4),286-290。 | 5. | Castello-Simões, V.、Minatel, V.、Karsten, M.、Simões, R. P.、Perseguini, N. M.、Milan, J. C.(2015)。Circulatory and ventilatory power: Characterization in patients with coronary artery disease。Arquivos Brasileiros de Cardiologia,104(6),476-485。 | 6. | Chen, S.、Dong, Y.、Yin, Y.、Krucoff, M. W.(2013)。Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: A meta-analysis。Heart,99(2),76-82。 | 7. | Clarke, L. A.、Hong, Y.、Eleftheriou, D.、Shah, V.、Arrigoni, F.、Klein, N. J.(2010)。Endothelial injury and repair in systemic vasculitis of the young。Arthritis and Rheumatology,62(6),1770-1780。 | 8. | Dietz, S. M.、Tacke, C. E.、Gort, J.、Kuipers, I. M.、de Groot, E.、Wiegman, A.(2015)。Carotid intima-media thickness in patients with a history of Kawasaki disease。Circulation Journal,2015(Oct.)。 | 9. | Fukazawa, R.、Ogawa, S.(2009)。Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis。Journal of Nippon Medical School,76(3),124-133。 | 10. | Gersony, W. M.(2009)。The adult after Kawasaki disease the risks for late coronary events。Journal of the American College of Cardiology,54(21),1921-1923。 | 11. | Holman, R. C.、Curns, A. T.、Belay, E. D.、Steiner, C. A.、Schonberger, L. B.(2003)。Kawasaki syndrome hospitalizations in the United States, 1997 and 2000。Pediatrics,112,495-501。 | 12. | Huang, W. C.、Huang, L. M.、Chang, I. S.、Chang, L. Y.、Chiang, B. L.、Chen, P. J.(2009)。Epidemiologic features of Kawasaki disease in Taiwan。Pediatrics,123(3),e401-e405。 | 13. | Huang, S. K.、Lin, M. T.、Chen, H. C.、Huang, S. C.、Wu, M. H.(2013)。Epidemiology of Kawasaki disease: prevalence from national database and future trends projection by system dynamics modeling。Journal of Pediatrics,163(1),126-131。 | 14. | Kato, H.、Sugimura, T.、Akagi, T.、Sato, N.、Hashino, K.、Maeno, Y.(1996)。Long-term consequences of Kawasaki disease: A 10- to 21-year follow-up study of 594 patients。Circulation,94,1379-1385。 | 15. | Kato, H.、Akagi, T.、Sugimura, T.、Sato, N.、Kazue, T.、Hashino, K.(1995)。Kawasaki disease。Coronary Artery Disease,6,194-206。 | 16. | Liu, Y.、Onouchi, Z.、Sakata, L.、Ikuta, K.(1996)。An experimental study on the role of smooth muscle cells in the pathogenesis of atherosclerosis of the corornary arteritis。Nippon Shonika Gakkai Zasshi,100,1453-1458。 | 17. | Nakamura, Y.、Yashiro, M.、Uehara, R.、Sadakane, A.、Tsuboi, S.、Aoyama, Y.(2012)。Epidemiologic features of Kawasaki disease in Japan: Results of the 2009-2010 nationwide survey。Journal of Epidemiology,22,216-221。 | 18. | Newburger, J. W.、Takahashi, M.、Gerber, M. A.、Gewitz, M. H.、Tani, L. Y.、Burns, J. C.(2004)。Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association。Pediatrics,114(6),1708-1733。 | 19. | Park, Y. W.、Han, J. W.、Hong, Y. M.、Ma, J. S.、Cha, S. H.、Kwon, T. C.(2010)。Epidemiological features of Kawasaki disease in Korea, 2006-2008。Pediatrics International,53,36-39。 | 20. | Rowley, A. H.、Shulman, S. T.(2010)。Recent advances in the understanding and management of kawasaki disease。Current Infectious Disease Reports,12,96-102。 | 21. | Shah, V.、Christov, G.、Mukasa, T.、Brogan, K. S.、Wade, A.、Eleftheriou, D.(2015)。Cardiovascular status after Kawasaki disease in the UK。Heart,101(20),1646-1655。 | 22. | Shulman, S. T.、Inocencio, J.、Hirsch, R.(1995)。Kawasaki disease。Pediatric Clinics of North America,42,1205-1222。 | 23. | Terai, M.、Shulman, S. T.(1997)。Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose。Journal of Pediatrics,131(6),888-893。 | 24. | Tobayama, H.、Takahashi, K.、Fukunaga, H.、Matsui, K.、Tanaka, N.、Harada, M.(2013)。Analysis of arterial function in adults with a history of Kawasaki disease。Journal of Cardiology,61(5),330-335。 | 25. | Uehara, R.、Belay, E. D.(2012)。Epidemiology of Kawasaki disease in Asia, Europe, and the United States。Journal of Epidemiology,22,79-85。 | 26. | Wood, L.、Tulloh, R.(2007)。Kawasaki disease: diagnosis, management and cardiac sequelae。Expert Review of Cardiovascular Therapy,5,553-561。 | 27. | Yoshikawa, J.、Yanagihara, K.、Owaki, T.、Kato, H.、Takagi, Y.、Okumachi, F.(1979)。Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome。Circulation,59,133-139。 | 研究報告1. | 宋鴻樟(1999)。評估人體暴露量、人體健康效應和空氣污染監測數據之關係--肺功能不良與空氣污染之關係。臺北市:國立臺灣大學公共衛生學院環境衛生研究所。 延伸查詢 | 圖書1. | American College of Sports Medicine(2006)。ACSM's Resource manual for guidelines for exercise testing and prescription。Baltimore, MD:Lippincott Williams & Wilkins。 | |